Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one ...

A team of scientists has developed a remarkable new approach to modeling how cells behave over time—using a digital "forecast" much like predicting the weather. By combining patient genomics with a ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that new preclinical data for its proprietary SPiKE platform has been accepted ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Earlier computational models helped scientists categorize ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

One of the holy grails of biology is digitally simulating a living cell. If researchers can use computers to more accurately understand how new medicines would react in the body, that could give them ...

A single-dose of Trogenix's proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

A moving cell looks simple from a distance. One edge pushes forward, the rest follows, and the whole thing creeps along as if ...

Checkpoint inhibitors have transformed cancer treatment over the past decade, helping hundreds of thousands of patients by ...